This year, GINA launched a campaign to urge governments and health officials to do more to improve asthma control. The campaign seeks to reduce asthma hospitalization by fifty percent in five years.
VOICE TWO:
Earlier this year, researchers identified what they hope will be a new tool in the fight against asthma. They said a new, non-steroidal treatment made from a human protein has proven successful in greatly decreasing the signs of asthma in mice.
The researchers said the protein, called IGFBP3, prevented the development of some physiological conditions linked to asthma. This includes inflammation and over activity of the lungs.
The researchers say the protein attacks an important cellular pathway called nuclear factor kappa B. NFkB is responsible for the lung inflammation linked to asthma. The discovery could have a major effect on asthma, as well as other respiratory problems related to inflammation, like rheumatoid arthritis and atherosclerosis.
The results of the study were made public earlier this year at the Endocrine Society's ninety-second annual meeting in San Diego, California.
(MUSIC)
VOICE ONE:
This SCIENCE IN THE NEWS was written by June Simms, who was also our producer. I'm Faith Lapidus.
VOICE TWO:
And I'm Bob Doughty. Archives of our programs are at voaspecialenglish.com. Join us again next week for SCIENCE IN THE NEWS in VOA Special English.
最新
2013-11-25
2013-11-25
2013-11-25
2013-11-25
2013-11-25
2013-11-25